3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
19
Lung Neoplasms
18
Breast Neoplasms
12
Multiple Myeloma
10
Carcinoma, Non-Small-Cell Lung
9
Leukemia, Myeloid, Acute
8
Rectal Neoplasms
7
Carcinoma, Hepatocellular
7
Myelodysplastic Syndromes
6
Mouth Neoplasms
6
Sarcoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Pancreatic Neoplasms
5
Oropharyngeal Neoplasms
5
Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Head and Neck Neoplasms
5
Brain Neoplasms
5
Ovarian Neoplasms
4
Melanoma
4
Lymphoma, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Glioma
4
Fallopian Tube Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Lymphoma, T-Cell
3
Lymphoma, Non-Hodgkin
3
Laryngeal Neoplasms
3
Interventions
pembrolizumab
12
Radiotherapy
9
avelumab
8
Nivolumab
8
cemiplimab
4
Radiation
4
Ipilimumab
4
poly ICLC
3
atezolizumab
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Etoposide
3
Cyclophosphamide
3
talimogene laherparepvec
2
lutetium Lu 177 dotatate
2
fludarabine phosphate
2
fludarabine
2
durvalumab
2
aldesleukin
2
Interferon-beta
2
Immunoglobulin G
2
Immune Checkpoint Inhibitors
2
Cisplatin
2
Carboplatin
2
Biopsy
2
veliparib
1
vatalanib
1
tremelimumab
1
tocilizumab
1
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Merkel Cell
×
X-Rays
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled